Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis
Deep Dutta, A B Kamrul-Hasan, Lakshmi Nagendra, Saptarshi Bhattacharya
Abstract
This meta-analysis provides exciting data on the impressive weight loss properties of tirzepatide over 72 weeks of clinical use in individuals with obesity without diabetes.
Topics & Concepts
MedicineDiabetes mellitusAgonistMeta-analysisGlucagon-like peptide 1 receptorType 2 diabetesObesityDual (grammatical number)Internal medicinePharmacologyEndocrinologyReceptorLiteratureArtPharmacology and Obesity TreatmentDiabetes Treatment and ManagementBariatric Surgery and Outcomes